M. Molls

13.4k total citations · 1 hit paper
318 papers, 9.8k citations indexed

About

M. Molls is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, M. Molls has authored 318 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Pulmonary and Respiratory Medicine, 94 papers in Radiology, Nuclear Medicine and Imaging and 68 papers in Cancer Research. Recurrent topics in M. Molls's work include Advanced Radiotherapy Techniques (55 papers), Cancer, Hypoxia, and Metabolism (50 papers) and Glioma Diagnosis and Treatment (45 papers). M. Molls is often cited by papers focused on Advanced Radiotherapy Techniques (55 papers), Cancer, Hypoxia, and Metabolism (50 papers) and Glioma Diagnosis and Treatment (45 papers). M. Molls collaborates with scholars based in Germany, Norway and United States. M. Molls's co-authors include Carsten Nieder, Anca-Ligia Grosu, Nicolaus Andratschke, Frank Zimmermann, Gabriele Multhoff, Markus Schwaiger, Wolfgang Weber, Hans Geinitz, Peter F. Stadler and Jürgen Radons and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

M. Molls

311 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

2005 739 citations M. Molls et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by M. Molls

Since Specialization

Citations

This map shows the geographic impact of M. Molls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Molls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Molls more than expected).

Fields of papers citing papers by M. Molls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Molls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Molls. The network helps show where M. Molls may publish in the future.

Co-authorship network of co-authors of M. Molls

This figure shows the co-authorship network connecting the top 25 collaborators of M. Molls. A scholar is included among the top collaborators of M. Molls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Molls. M. Molls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients – Long term data on toxicity and biochemical control 2019 ·Reports of Practical Oncology & Radiotherapy ·Kilian Schiller, (unknown), Marciana Nona Duma, Carsten Nieder, M. Molls, Stephanie E. Combs, Hans Geinitz	5
2	Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines 2012 ·Strahlentherapie und Onkologie ·Daniela Schilling, Christine Bayer, Karl-Heinz Emmerich, M. Molls, Peter Vaupel, Roman Huber, Gabriele Multhoff	12
3	Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report 2009 ·Journal of Translational Medicine ·Valeria Milani, Stefan Stangl, Rolf D. Issels, Mathias Gehrmann, (unknown), (unknown), Doris Mayr, Wolfgang Hiddemann, M. Molls, Gabriele Multhoff	28
4	Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) 2006 ·Acta Oncologica ·Frank Zimmermann, Hans Geinitz, Sabine Schill, Reinhard Thamm, Carsten Nieder, Ulrich Schratzenstaller, M. Molls	122
5	Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer 2006 ·Radiotherapy and Oncology ·Hans Geinitz, Frank Zimmermann, Reinhard Thamm, (unknown), Tobias Müller, Monika Keller, Raymonde Busch, M. Molls	31
6	High-Precision Radiation Therapy with Integrated Biological Imaging and Tumor Monitoring 2006 ·Strahlentherapie und Onkologie ·Anca-Ligia Grosu, M. Molls, Frank Zimmermann, Hans Geinitz, Fridtjof Nüsslin, Markus Schwaiger, Carsten Nieder	20
7	Evaluation of insulin-like growth-factor-1 as a protective agent against radiation-induced kidney dysfunction in C3h mice: A dose-finding study 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Lei Cai, Wolfgang Weber, Sabine Schill, Sabrina T. Astner, Nicolaus Andratschke, M. Molls, Carsten Nieder	1
8	A risk score for human spinal cord re-irradiation based on clinical data from 40 patients 2004 ·mediaTUM (Technical University of Munich) ·Nicolaus Andratschke, Carsten Nieder, (unknown), M. Molls	4
9	Indikationen zur neoadjuvanten Therapie beim Rektumkarzinom 2003 ·Der Chirurg ·Frank Zimmermann, M. Molls	1
10	Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review 2003 ·Cancer Treatment Reviews ·Carsten Nieder, Thomas Licht, Nicolaus Andratschke, Christian Peschel, M. Molls	18
11	Qualitätsmanagement und Erfahrungen mit dem „Cancer Center“ 2002 ·DMW - Deutsche Medizinische Wochenschrift ·M. Siess, R. Bumm, M. Molls, C. Peschel, J. R. Siewert	6
12	Three-dimensional radiation treatment : technological innovations and clinical results 2000 ·KARGER eBooks ·H.J. Feldmann, P. Kneschaurek, M. Molls	3
13	Strahlentherapie des alten Patienten : Verträglichkeit und Ergebnisse der Strahlentherapie älterer Personen 1999 ·Strahlentherapie und Onkologie ·Hans Geinitz, Frank Zimmermann, M. Molls	2
14	The Value of Iodine-123-Alpha-Methyl-<i>L</i>-Tyrosine Single-Photon Emission Tomography for the Treatment Planning of Malignant Gliomas 1999 ·Frontiers of radiation therapy and oncology ·(unknown), Anca-Ligia Grosu, Wolfgang Weber, Peter Bartenstein, (unknown), Markus Schwaiger, M. Molls	2
15	Blood perfusion and microenvironment of human tumors : implications for clinical radiooncology 1998 ·Springer eBooks ·M. Molls, Peter Vaupel	62
16	The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas 1998 ·International Journal of Radiation OncologyBiologyPhysics ·Markus W. Groß, Wolfgang Weber, Horst Jürgen Feldmann, Peter Bartenstein, Markus Schwaiger, M. Molls	72
17	Oxygen Tension in Isotransplanted Mammary Carcinomas and Osteosarcomas Before and After Irradiation 1996 ·Advances in experimental medicine and biology ·(unknown), Thomas Auberger, H.J. Feldmann, R. Senekowitsch, K. Tempel, M. Molls	7
18	[Problems of radiotherapy in Germany after the recent events in Hamburg]. 1994 ·PubMed ·Hans‐Peter Beck‐Bornholdt, Michaël Baumann, Torsten Herrmann, M. Molls, R. Sauer, K.R. Trott	1
19	The Influence of G ₂ Progression on X-ray Sensitivity of Two-cell Mouse Embryos 1984 ·International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine ·M. Molls, C. Streffer	19
20	How relevant is the labelling index for cell proliferation 1980 ·Europe PMC (PubMed Central) ·C. Streffer, D. van Beuningen, M. Molls, Nikolaos Zamboglou	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact